Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2419-2428
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2419
Table 4 Differentially abundant metabolite information between the merged group and the control group
MS2
MS2
Ingredient
VIP
Difference multiple
P value
2-aminoacetophenone1.000000000Aromatic compounds2.9618045132.1969074220.015884556
Alpha-N-phenylacetyl0.999461308A-N-phenylacetyl2.9227374652.9285942660.015713599
Arginyl-alaninr0.538666308Argininylalanine2.8707195410.5778067670.000093284
Pseudouridine0.761171308pseudouridine2.6547583981.2094684190.010376873
N-methylnicotinamide0.695534769N-methylnicotinamide2.5965653500.4361873880.023415222
Dopamine 3-O0.583639154Dopamine 3-O-monosulfate2.5083484821.4745594600.045180328
Choline1.000000000Choline2.4857580300.8746595130.004134701
N4-acetylcytidine0.990193846N-acetylcytosine nucleoside2.4857517261.4589211220.001565543
N-acetyl-L-alanine0.907531231N-acetyl-L-alanine2.4628962661.1450115180.020139388
Bliverdin0.981282462Biliverdin2.4451973020.4899045040.003203639